Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Clinical trial NCT04620135 · COMPLETED
Trial details
- NCT number
- NCT04620135
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-07-09
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.